Aerogen Announces €300 Million Investment, Adding 725 Jobs in Ireland

Deal News | Jan 15, 2025 | Enterprise Ireland

Enterprise Ireland's 2024 results reveal a record employment surge, with Aerogen announcing a significant €300 million investment plan set to generate 725 jobs in Galway and Shannon. This expansion consolidates Aerogen's position as a leader in medtech innovation and contributes to Ireland's economic growth. In alignment with Enterprise Ireland's goal to bolster Irish multinationals, Aerogen's plan exemplifies robust advancement in the medtech sector. The company, renowned for its respiratory drug delivery devices, aims to innovate within the biopharmaceuticals space, particularly targeting premature newborns' treatment. The scaling plan is expected to enhance Aerogen's workforce to over 2,000 globally by 2035. Minister Peter Burke underscores the announcement's importance in driving Ireland's competitive edge. Despite challenges like high interest rates, Enterprise Ireland demonstrates resilience with a 3% employment increase and growth in critical sectors. Collective achievements highlight Ireland's commitment to nurturing globally competitive, Irish-owned companies.

Sectors

  • Medical Technology
  • Biopharmaceutics

Geography

  • Ireland – Aerogen's expansion and Enterprise Ireland's employment results are concentrated in Ireland, particularly impacting regions like Galway and Shannon.

Industry

  • Medical Technology – The article focuses on Aerogen, a leading medtech company specializing in acute care aerosol drug delivery, highlighting their significant expansion within this industry.
  • Biopharmaceutics – Aerogen's strategic plan includes a focus on developing its biopharmaceutical business, aiming to improve treatments for conditions like Infant Respiratory Stress Syndrome.

Financials

  • €300 million – The investment amount for Aerogen's ten-year scaling and investment plan.
  • €150 million – Aerogen's current annual revenue.

Participants

NameRoleTypeDescription
AerogenTarget CompanyCompanyAerogen is Ireland's largest indigenous medtech company, specializing in acute care aerosol drug delivery, with over 25 years of expertise.
Enterprise IrelandSupporting OrganizationGovernmentEnterprise Ireland is a government agency supporting business development and expansion, instrumental in Aerogen's growth and sectoral employment growth.
Peter BurkeMinister for Enterprise, Trade and EmploymentPersonPeter Burke is involved in supporting and delivering Enterprise Ireland's results and advocating for the scaling of Irish multinational companies.
Leo ClancyCEO of Enterprise IrelandPersonLeo Clancy outlines the strategic goals of Enterprise Ireland, highlighting the significance of Aerogen's expansion and employment statistics.